Home
About
Overview
Sharing Data
ORCID
Help
History (108)
20-Hydroxysteroid Dehydrogenases
Receptor, Fibroblast Growth Factor, Type 2
Stetson, Nathaniel
Freedom
Preventing systemic embolism in patients with abnormal ventricular function.
See All 108 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Preventing systemic embolism in patients with abnormal ventricular function.
Preventing systemic embolism in patients with abnormal ventricular function. Cardiol Clin. 1994 Aug; 12(3):477-85.
View in:
PubMed
subject areas
Anticoagulants
Cardiomyopathy, Dilated
Clinical Trials as Topic
Embolism
Heart Aneurysm
Heart Neoplasms
Humans
Myocardial Infarction
Platelet Aggregation Inhibitors
Thrombolytic Therapy
Ventricular Dysfunction
authors with profiles
Gary E Raskob
Philip Cinnamon Comp